| Product | HA | PN | Indications | Format | Needles |
|---|---|---|---|---|---|
| PNOVA | - | PN 20 mg/mL |
Skin concerns addressed - Reduction of fine lines and wrinkles - Improvement of dry and dull skin - Reduction in the appearance of enlarged pores - Improvement of uneven skin texture Target treatment areas - Full face rejuvenation in adult patients - Fine to moderate wrinkles - Periorbital lines - Perioral wrinkles - Other areas where improvement of skin quality and a regenerative approach is preferred over strong volumizing Duration of effect: Up to 24 weeks. |
2 mL x syringe/ BOX | - |
2026 New launched product